Thank you for registering
We’d hate for you to miss this event – add it to your calendar using the button below and join leading HCPs for valuable insights and discussions.
Sign up to the Myeloma UK HCP Hub
Get free access to educational resources, expert-written articles, clinical tools and event updates — all tailored for professionals working in myeloma.
Watch previous UKMS/Myeloma UK webinars
Digital Infosession: Renal disease in myeloma and related conditions
The fourth co-partnered digital infosession from Myeloma UK and UKMS, held on 16 October 2024 and hosted by Professor Gordon Cook, covers cutting-edge strategies for managing renal complications in myeloma, including myeloma cast nephropathy, paraprotein-related kidney disease, and comprehensive treatment and supportive care approaches.
Digital Infosession: Guidance for managing bone disease and optimal imaging for patients with myeloma
Joining forces once again, Myeloma UK and the UK Myeloma Society (UKMS) proudly present their third co-partnered digital infosession. Chaired by Professor Guy Pratt, this webinar, held on 16 April 2024, brought together top experts for an engaging discussion on effective strategies for managing bone disease in myeloma patients.
Digital Infosession: Effective management of multidisciplinary MGUS and myeloma clinics
Myeloma UK and the UK Myeloma Society (UKMS) are excited to present their second co-partnered digital infosession, chaired by Prof. Guy Pratt. This webinar, recorded on 18 October 2023, features leading experts discussing best practices for managing multidisciplinary clinics, offering valuable guidance for healthcare professionals involved in MGUS and myeloma care.
Digital Infosession: BCMA and GPRC5D antibodies in practice: Implementation and management for healthcare professionals
Myeloma UK and the UK Myeloma Society (UKMS) proudly present their first co-partnered digital infosession. This recording of the live event, held on 19 April 2023, features expert speakers from medicine, nursing, and pharmacy, sharing insights on the innovation journey of these treatments such as bispecific antibodies and offering practical guidance on their implementation and management in clinical practice.